Status: Not yet recruiting
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.
Participants needed: 210
Trial details
Phase: Phase 3Age: 18-85Biological sex: AllType: InterventionalSponsor: Braveheart Bio, Inc.Updated: Aug 10, 2026
Eligibility criteria
Diagnosed with oHCM per the protocol specified criteria [+3]
Medical indication for either β-blocker or calcium-channel blocker therapy, othe... [+5]